amroui
02-28 21:17

Chanced upon $Microbot Medical Inc(MBOT)$  just before they showcased their LIBERTY system at the intravenous treatment medical conference. Oversold, with a product waiting for adoption brimming with potential, this looked like an opportunity too good to miss.

With a price hovering around $1.70~$1.80, I quickly snapped up some call options at $0.30 each. I was planning to go long on this stock anyway, given their plan to advocate for their LIBERTY system adoption throughout 2026 and 2027, they're just at the starting line of a value expansion cycle. 

Within a couple of weeks, their showcase was a success, and the first major adoption by a major hospital was announced. Their price shot up quickly to $2.50 and I was able to cash out on half my call options, recovering my capital and making a small profit as well.

I'm honestly surprised at the speed of progress that has happened, and I think the price might retreat a little. If it does pull back to ~$2 anytime from now to end April, I'll probably load up more on this stock. Banking on this stock to exceed $3 by next year, maybe even $5? [Smart]  [USD]  

For now, I'm trying to get discounts on loading up by shorting Put options. Hoping to short them to acquire more units at a net value of $1.80 or lower [Serious]  [Miser]  

Winning Trades
Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment